Is zovaglutide available for purchase?

No. Zovaglutide (ZT-002) is an investigational monthly GLP-1 agonist developed by QL Biopharm. It has advanced to Phase 3 clinical trials but is not available through any pharmacy or peptide vendor.

What makes zovaglutide different from other GLP-1 drugs?

Zovaglutide features a dual-fatty acid chain design that extends its half-life to enable once-monthly subcutaneous dosing. In Phase 2, the 160 mg monthly dose achieved 13.8% weight loss at 24 weeks with only 1.3% GI-related discontinuation, suggesting potentially better GI tolerability than some weekly GLP-1 agonists.

How does zovaglutide compare to MariTide and MET-097i?

All three target monthly dosing for obesity but use different approaches. Zovaglutide is a pure GLP-1 agonist with dual-fatty acid chain extension. MariTide combines GLP-1 agonism with GIPR antagonism via antibody conjugation. MET-097i uses the HALO platform for half-life extension. Zovaglutide has the most advanced development status among pure monthly GLP-1 agonists, having entered Phase 3.

Zovaglutide: Community Protocols & Reports

Aggregated community experiences, protocols, and stacking patterns

Anecdotal Reports0

Community-Sourced Information

The protocols and reports on this page are gathered from online communities and forums. They represent anecdotal experiences, not clinical evidence. Individual results vary significantly. This information is not medical advice and should not replace consultation with a qualified healthcare provider. Always verify dosing and safety information with peer-reviewed research before making any decisions.

For peer-reviewed dosing protocols, see the clinical dosing guide.

Browse community protocols for all 130 peptides →

✓Reviewed byEditorial Team

📅Updated February 16, 2026

Unverified

📌TL;DR

•Community protocols detailed below
•Evidence level: Anecdotal Reports
•See community reports below
•Stacking patterns detailed below

Sources

Reddit r/Peptides|Monthly GLP-1 agonist pipeline discussions(accessed 2026-02-16)
Reddit r/loseit|Next-generation obesity drug pipeline discussions(accessed 2026-02-16)

Community Evidence Overview#

This page documents the community evidence landscape for zovaglutide (ZT-002). This is not clinical evidence and should not be used as medical guidance.

Zovaglutide has no community self-experimenter data. It is an investigational monthly GLP-1 agonist that has entered Phase 3 clinical trials.

Why There Is No Community Data#

Investigational Pharmaceutical Development#

Zovaglutide is developed by QL Biopharm through traditional pharmaceutical channels. The compound's proprietary dual-fatty acid chain design has not been publicly disclosed in sufficient detail for independent synthesis.

Phase 3 Status#

While zovaglutide has advanced to Phase 3 clinical trials (among the most advanced monthly GLP-1 candidates), it remains available only to clinical trial participants.

Community Interest in Monthly Dosing#

The prospect of monthly GLP-1 dosing generates significant community interest:

Injection fatigue: Many current weekly semaglutide and tirzepatide users report the cumulative burden of weekly injections
Adherence: Monthly dosing could improve treatment adherence, a key factor in long-term weight management
GI tolerability: Zovaglutide's low 1.3% GI-related discontinuation rate is frequently cited as a potential advantage over weekly GLP-1 agonists
Supply chain: Monthly products may be less susceptible to the supply shortages that have affected weekly GLP-1 agonists

Competitive Positioning#

Zovaglutide is one of three major monthly dosing candidates alongside MariTide (Amgen) and MET-097i (Pfizer). Community discussions often compare these candidates on efficacy, tolerability, and timeline to potential approval.

Zovaglutide Research & Clinical Studies
Zovaglutide Molecular Profile
MariTide - Antibody-peptide conjugate monthly approach
MET-097i - HALO platform monthly GLP-1
Semaglutide - Current weekly GLP-1 standard

Subscribe to see vendor options

Free access to verified vendor scores, pricing, and suppliers.

150+ peptide profiles · 30+ comparisons · 18 research tools

Already subscribed?

Frequently Asked Questions About Zovaglutide

Explore Further

Calculate your dose

Reconstitution volumes, injection doses, and supply planning

⚠️

Medical Disclaimer

This website is for educational and informational purposes only. The information provided is not intended to diagnose, treat, cure, or prevent any disease. Always consult with a qualified healthcare professional before using any peptide or supplement.

Compare Tools Vendors